Despite the popular interest in gluten and gluten related disorders, studies of the biological mechanisms underlying non-celiac gluten sensitivity (NCGS) are scarce. This study identified amylase trypsin inhibitors in wheat that act as potent stimulators of innate immune reactions, notably the stimulation of Toll-like receptor 4 (TLR4) in monocytes, macrophages and dendritic cells, which release a number of cytokines including interleukin (IL)-8 and tumor necrosis factor (TNF)-α in blood from celiac patients as well as healthy subjects and in intestinal biopsies from coeliacs. These data suggest an activation avenue that applies both to celiac disease as well as to NCGS or other inflammatory conditions. However, no further documentation that amylase trypsin inhibitors are involved in NCGS has so far emerged. This Recommendation is of an article referenced in an F1000Prime Report also written by Steffen Husby and Joseph Murray.